CD19 and lymphoma: CD19 CAR NK cell exhibited significantly superior cytotoxicity against anti‐CD20 resistant lymphoma cells via longer contact duration with target cells, increased secretion of FasL, C‐C motif chemokine ligand (CCL3, and IL10 as well as inducing genes related to mTOR and cell cycle checkpoint activation.181